Uveal Melanoma Immunogenomic Score Shows Predictive Potential
Investigators examined 100 metastases and developed a Uveal Melanoma Immunogenomic Score to predict which patients will respond to immunotherapy.
Stay updated with breaking news from Solid Tumor Cell Therapy Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investigators examined 100 metastases and developed a Uveal Melanoma Immunogenomic Score to predict which patients will respond to immunotherapy.
Researchers have found a treatment that works on some patients and, more importantly, a tool that can predict when it is likely to succeed.
Distinguished leaders in immunology and translational oncology join to support the Company's scientific approachStrengthening the focus on solid tumors and progressing two programs towards the
Investegate announcements from Achilles Therapeutics PLC, Achilles Therapeutics Appoints James Taylor as Chief Business Officer and Cassian Yee, MD to Scientific Advisory Board